Review
Accepted on 09 Jun 2025
Centralized Daily Drug Management in Clinical Trial Institutions and Specific Implementation Plans
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1620314
80 Publications
Volume 5 - 2025
Original Research
Accepted on 02 Jun 2025
Identifying regulatory outcomes of non-interventional Post Authorisation Safety Studies in the European repository of studies using publicly available information
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1574430
- 136 views
Methods
Published on 26 May 2025
Federated learning: a privacy-preserving approach to data-centric regulatory cooperation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579922
- 865 views
Review
Published on 24 Apr 2025
Corticosteroids in lung cancer
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1528468
- 742 views
Original Research
Published on 13 Mar 2025
Developing decision support algorithm for hypertension medications for use in a digital therapeutic system
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1476998
- 596 views
Editorial
Published on 11 Mar 2025
Editorial: External control arms for single-arm studies: methodological considerations and applications
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579171
- 917 views
Perspective
Published on 13 Feb 2025
Implementing tokenization in clinical research to expand real-world insights
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1519307
- 1,554 views
Volume 4 - 2024
Review
Published on 17 Jan 2025
Integrating environmental effects in the benefit-risk assessment of therapeutic products: a proposal and example for sustainable health and healthcare
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1519142
- 1,235 views
Original Research
Published on 16 Jan 2025
The safety and efficacy of neutral electrolyzed water solution for wound irrigation: post-market clinical follow-up study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1402684
- 1,363 views
Original Research
Published on 06 Jan 2025
Detection of nontoxic BoNT/A levels in post-facial Botox injection breastmilk
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1480515
- 1,866 views
Review
Published on 18 Dec 2024
Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studies
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1418050
- 1,534 views
Original Research
Published on 06 Dec 2024
Influence of differential source patterns in the detection of signals of disproportionate reporting for PARP inhibitors
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1497116
- 926 views
Mini Review
Published on 13 Nov 2024
Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1428831
- 1,184 views
Editorial
Published on 13 Nov 2024
Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1517365
- 1,268 views
- 1 citation
Perspective
Published on 30 Oct 2024
External comparator studies and the joint application of the estimand and target trial emulation frameworks
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1409102
- 1,296 views
Opinion
Published on 18 Sep 2024
Achieving synchrony: bridging the gap between pharmaceutical companies and regulators on safety labeling updates
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1477516
- 1,626 views
- 1 citation